Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals

This study has been completed.

Sponsor:

Collaborator:

National Institute on Drug Abuse (NIDA)

Information provided by (Responsible Party):

Phillip Coffin, MD, MIA, San Francisco Department of Public Health

ClinicalTrials.gov Identifier:

NCT00497055

First received: July 5, 2007

Last updated: May 9, 2012

Last verified: May 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	March 2012
Primary Completion Date:	March 2012 (Final data collection date for primary outcome measure)

No publications provided by San Francisco Department of Public Health

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Coffin PO, Santos GM, Das M, Santos DM, Huffaker S, Matheson T, Gasper J, Vittinghoff E, Colfax GN. Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction. 2013 Apr;108(4):751-61. doi: 10.1111/add.12073. Epub 2013 Jan 3.

To Top